The effects of probiotic and synbiotic supplementation on inflammatory markers among patients with diabetes: A systematic review and meta-analysis of randomized controlled trials.


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
05 Jun 2019
Historique:
received: 18 01 2019
revised: 28 03 2019
accepted: 02 04 2019
pubmed: 9 4 2019
medline: 4 9 2019
entrez: 9 4 2019
Statut: ppublish

Résumé

This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to evaluate the effect of probiotic and symbiotic supplementation on inflammatory markers among patients with diabetes. Clinical trials were searched using Cochrane Library, EMBASE, PubMed, and Web of Science online databases for relevant trials published until April 2018. Two independent investigators evaluated study eligibility, extracted data, and assessed risk of bias of included clinical trials. Cochran's Q test and I-square (I

Identifiants

pubmed: 30959049
pii: S0014-2999(19)30231-6
doi: 10.1016/j.ejphar.2019.04.003
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-264

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Reza Tabrizi (R)

Health Policy Research Center, Institute of Health, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Vahidreza Ostadmohammadi (V)

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R, Iran.

Kamran B Lankarani (KB)

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Akbari (M)

Health Policy Research Center, Institute of Health, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Hamideh Akbari (H)

Department of Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

Sina Vakili (S)

Department of Biochemistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Shokrpour (M)

Department of Gynecology and Obstetrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran. Electronic address: drshokrpour@gmail.com.

Fariba Kolahdooz (F)

Indigenous and Global Health Research, Department of Medicine, University of Alberta, Edmonton, Canada.

Vajihe Rouhi (V)

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R, Iran.

Zatollah Asemi (Z)

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R, Iran. Electronic address: asemi_r@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH